Par Pharmaceutical Announces Quarterly Conference Call
WOODCLIFF LAKE, N.J., May 8, 2013 /PRNewswire/ — Par Pharmaceutical Companies, Inc. announced today that it will host a conference call on Thursday, May 16, 2013, at 10:00 a.m. EDT to review its results of operations for the quarter ended March 31, 2013. Par is privately held and does not generally make its financial information available to the public. However, holders of Par’s debt securities, certain prospective holders of Par’s debt securities and research analysts who cover or intend to cover Par and its debt securities may participate in the conference call and request access to the secured area of its website, in which Par provides access to its financial reports and certain other information relating to its business. Par will make its first quarter 2013 reporting package available on Par’s secured website prior to the call. Information concerning access to the conference call and to Par’s reporting package is posted on Par’s secured website at www.parpharm.com/financial information.
About Par Pharmaceutical Companies
Par Pharmaceutical Companies, Inc. is a privately-held, U.S.-based specialty pharmaceutical company. Through its wholly-owned subsidiary’s two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals, it develops, manufactures and markets high-barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals. For press release and other company information, visit www.parpharm.com.
SOURCE Par Pharmaceutical Companies